These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 32407947

  • 1. Intralymphatic immunotherapy for mountain cedar pollinosis: A randomized, double-blind, placebo-controlled trial.
    Thompson CP, Silvers S, Shapiro MA.
    Ann Allergy Asthma Immunol; 2020 Sep; 125(3):311-318.e2. PubMed ID: 32407947
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
    Hylander T, Larsson O, Petersson-Westin U, Eriksson M, Kumlien Georén S, Winqvist O, Cardell LO.
    Respir Res; 2016 Jan 27; 17():10. PubMed ID: 26817454
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.
    Clin Ther; 2011 Jul 27; 33(7):828-40. PubMed ID: 21741092
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Sustained effects of intralymphatic pollen-specific immunotherapy on Japanese cedar pollinosis.
    Terada T, Omura S, Kikuoka Y, Suzuki M, Inaka Y, Inui T, Matsuda M, Nabe T, Kawata R.
    Rhinology; 2020 Jun 01; 58(3):241-247. PubMed ID: 32091032
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-Term Efficacy and Dose-Finding Trial of Japanese Cedar Pollen Sublingual Immunotherapy Tablet.
    Gotoh M, Yonekura S, Imai T, Kaneko S, Horikawa E, Konno A, Okamoto Y, Okubo K.
    J Allergy Clin Immunol Pract; 2019 Apr 01; 7(4):1287-1297.e8. PubMed ID: 30537561
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis.
    Okamoto Y, Okubo K, Yonekura S, Hashiguchi K, Goto M, Otsuka T, Murata T, Nakao Y, Kanazawa C, Nagakura H, Okawa T, Nakano K, Hisamitsu M, Kaneko S, Konno A.
    Int Arch Allergy Immunol; 2015 Apr 01; 166(3):177-88. PubMed ID: 25895909
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Kunii N, Yamamoto H, Sakurai D, Hanazawa T.
    Arerugi; 2008 May 01; 57(5):558-61. PubMed ID: 18520178
    [Abstract] [Full Text] [Related]

  • 18. Short course of grass allergen peptides immunotherapy over 3 weeks reduces seasonal symptoms in allergic rhinoconjunctivitis with/without asthma: A randomized, multicenter, double-blind, placebo-controlled trial.
    Mösges R, Bachert C, Panzner P, Calderon MA, Haazen L, Pirotton S, Wathelet N, Durham SR, Bonny MA, Legon T, von Frenckell R, Pfaar O, Shamji MH.
    Allergy; 2018 Sep 01; 73(9):1842-1850. PubMed ID: 29512827
    [Abstract] [Full Text] [Related]

  • 19. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects.
    Ceuppens JL, Bullens D, Kleinjans H, van der Werf J, PURETHAL Birch Efficacy Study Group.
    Clin Exp Allergy; 2009 Dec 01; 39(12):1903-9. PubMed ID: 20085600
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen.
    Patel P, Holdich T, Fischer von Weikersthal-Drachenberg KJ, Huber B.
    J Allergy Clin Immunol; 2014 Jan 01; 133(1):121-9.e1-2. PubMed ID: 23870670
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.